How should we advise patients about the contraceptive patch, given the FDA warning?

Cleve Clin J Med. 2006 Jan;73(1):45-7. doi: 10.3949/ccjm.73.1.45.
No abstract available

MeSH terms

  • Contraceptives, Oral, Combined* / adverse effects
  • Counseling
  • Drug Combinations
  • Drug Utilization
  • Ethisterone / adverse effects
  • Ethisterone / analogs & derivatives*
  • Female
  • Humans
  • Norgestrel / adverse effects
  • Norgestrel / analogs & derivatives*
  • Oximes / adverse effects
  • Physician-Patient Relations
  • Practice Patterns, Physicians'
  • Risk Assessment
  • United States
  • United States Food and Drug Administration
  • Venous Thrombosis / chemically induced

Substances

  • Contraceptives, Oral, Combined
  • Drug Combinations
  • Oximes
  • Norgestrel
  • Ethisterone
  • norelgestromin